Needham & Company Downgrades Theravance Biopharma (TBPH) to Hold, Following Strategic Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. CRWD
4. ON
5. VRTX
6. INSP
7. RXRX
8. CHKP
9. HNGE
10. MTCH

Go back to Needham & Company Downgrades Theravance Biopharma (TBPH) to Hold, Following Strategic Business Update

Theravance Biopharma (TBPH) PT Lowered to $7 at Baird

September 16, 2021 8:17 AM EDT

Baird analyst Brian Skorney lowered the price target on Theravance Biopharma (NASDAQ: TBPH) to $7.00 (from $10.00) while maintaining a Neutral rating.

... More

Theravance Biopharma (TBPH) PT Lowered to $8 at Cowen

September 15, 2021 3:55 PM EDT

Cowen analyst Marc Frahm lowered the price target on Theravance Biopharma (NASDAQ: TBPH) to $8.00 (from $14.00) while maintaining a Market Perform rating.

The analyst commented, "Theravance announced that the Phase 3 SEQUOIA trial of ampreloxetine in nOH did not demonstrate an impact on the... More